SEC Form 4 · accession 0001548292-16-000002
AMERICAN BIO MEDICA CORP · ABMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melissa A Waterhouse
Officer — Chief Executive Officer · Director
Period of report
Jan 29, 2016
Accepted (ET)
Feb 2, 2016 · 2:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896747
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Statutory Stock OptionF1,F2 | $0.11 | Jan 29, 2016 | J | 750,000 | A | Jan 29, 2017 | Jan 29, 2026 | Common Shares | 750,000 | 750,000 | D |
Explanation of responses
- F1Closing price of the Company's common shares on the date of the grant.
- F2The option grant is exercisable as follows: 50% on January 29, 2017 and 50% on January 29, 2018.